Clinical Trial

BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy

Name: BHB-1893 Versus Metoprolol for Symptomatic Obstructive Hypertrophic Cardiomyopathy — clinical trial record (NCT07755904)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: LIONHEART-HCM

Not Yet Recruiting Phase 3

View on ClinicalTrials.gov →

Summary

The main purpose of this trial is to find out whether BHB-1893 works better than metoprolol in adults with symptoms of obstructive hypertrophic cardiomyopathy (oHCM). The trial includes adults who are currently being treated for oHCM or who have not yet been treated.

Trial Details

NCT Number	NCT07755904
Lead Sponsor	Braveheart Bio, Inc.
Conditions	Cardiomyopathy, Hypertrophic Obstructive
Enrollment	210 participants
Start Date	2026-10
Primary Completion	2028-10 (estimated)
Study Completion	2028-11 (estimated)
Updated on ClinicalTrials.gov	2026-08-10